HeraMED Limited (ASX:HMD)

Market Cap	48.61M +247.0%
Revenue (ttm)	431.61K -10.3%
Net Income	-4.13M
EPS	-0.00
Shares Out	1.16B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,545,153
Open	0.0410
Previous Close	0.0445
Day's Range	0.0410 - 0.0440
52-Week Range	0.0060 - 0.0550
Beta	0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 11, 2026

About Hatton National Bank

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women’s health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Haw...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: HMD

Financial Performance

In 2025, HeraMED's revenue was 431,605, a decrease of -10.31% compared to the previous year's 481,227. Losses were -4.13 million, -24.75% less than in 2024.